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Volume 54, Number 6 Letters to the Editor 1869basis of their underlying malignancy. Unfortunately, our study
does not provide definitive answers to the above-mentioned ques-
tions, but confirms that survival was low in the overall cohort, and
that CAS was performed with low peri-procedural risk but with
high restenoses rates. We continue to indicate carotid revascular-
ization after a careful discussion of our institutional results, the
risks of stroke or stroke-related disability, the patients overall
prognosis, and the anatomical characteristics of the lesion. In
general, patients with no evidence of recurrent cancer and who are
symptomatic and have suitable anatomy are treated by either CAS
or open surgery, depending on factors such as presence of concom-
itant radical neck dissection, tracheostomy, or skin damage. For
asymptomatic patients, we recognize that the indication of revas-
cularization remains controversial and that one should carefully
analyze the patient’s life expectancy and anatomical risk for the
procedure. However, carotid revascularization continues to have a
role in selective patients with significant progression of the carotid
lesion and no evidence of recurrentmetastatic disease or limited life
expectancy.
Gustavo S. Oderich, MD
Tiziano Tallarita, MD
Mayo Clinic
Rochester, Minn
REFERENCES
1. Tallarita T, Oderich GS, Lanzino G, Cloft H, Kallmes D, Bower TC, et
al. Outcomes of carotid artery stenting versus historical surgical controls
for radiation-induced carotid stenosis. J Vasc Surg 2011;53:629-36 e1-5.
2. Dorresteijn LD, Kappelle AC, Boogerd W, Klokman WJ, Balm AJ, Keus
RB, et al. Increased risk of ischemic stroke after radiotherapy on the neck
in patients younger than 60 years. J Clin Oncol 2002;20:282-8.
3. Cheng SW, Ting AC, Ho P, Wu LL. Accelerated progression of carotid
stenosis in patients with previous external neck irradiation. J Vasc Surg
2004;39:409-15.
4. Executive Committee for the Asymptomatic Carotid Atherosclerosis
Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA
1995;273:1421-8.
5. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al.
Prevention of disabling and fatal strokes by successful carotid endarter-
ectomy in patients without recent neurological symptoms: randomised
controlled trial. Lancet 2004;363:1491-502.
doi:10.1016/j.jvs.2011.07.035
Regarding “Evaluation of the Endurant stent graft
under instructions for use vs off label conditions for
endovascular aortic aneurysm repair”
We read the article by Torsello et al with interest.1 While the
use of endovascular aneurysm repair (EVAR) has revolutionized
the management of infrarenal abdominal aortic aneurysm (AAA)
its use has only been shown feasible in 40% to 60% of AAA.
Advances in technology, imaging, graft design, and operator expe-
rience has lead to an extension of their use beyond initial manufac-
turer’s guidelines. The device studied in this article is licensed to a
10-mm neck extending or rather shortening the previous bench-
mark of 15 mm. Nevertheless, the ability to place the graft at
operation outside this use is shown to be associated with increased
type I endoleak. Numbers did not reach significance as the primary
endpoint frequency was low and study group small.
We have previously shown that use of EVAR outside IFU was
associated with a worse outcome that translated into patient mor-
tality in symptomatic AAA.2 Recently we conducted a review of the
EUROSTAR database of over 75003 cases to determine the long-
term outcome of elective infrarenal endografts inserted outside the
manufacturers’ IFUs. We found a significant association between
a
ehe “off label” use of endografts and the incidence of type 1
ndoleak, which is in agreement with the authors. However, our
ata also showed that grafts placed outside IFU were associated
ith increased all-cause mortality and type I endoleak was
ssociated with increased aneurysm related mortality at long-
erm follow-up. The grafts in our study, however, were older
eneration and did not include the Endurant. These datasets
upport the authors comments that use of EVAR outside IFU
an be done but short-term results that may appear satisfactory
re in fact significantly worse in long-term follow-up.
We suggest that use of devices outside license or recom-
ended usage should be undertaken only in the centers with
obust data collection, or better still, in clinical trials. EVAR is an
xcellent prophylactic treatment for infrarenal AAA when under-
aken correctly, however, it appears less effective if outside IFU and
ncreases the risk for long-term failure. Long-term follow-up of
VAR has shown the early advantages of infrarenal EVARs over
pen surgery disappear with time.4 The consequence of using
off-label” stent grafts may have resulted in steadily increased
umbers of ruptured aneurysms. This has prompted us to resort to
more liberal use of fenestrated stent grafts, given the excellent
arly results with the latter.
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We read with interest the comment of Cross et al and we thank
hem for the attention paid to our article.
We completely agree with the authors that the use of en-
ografts outside the manufacturers’ instructions for use (IFU) was
esponsible of a higher risk of type I endoleak1; our population
tudy did not have the right power to obtain a statistical signifi-
ance, but we explained this bias in the text. Furthermore, our
ollow-up was too short to give rough conclusions.2
Then, we agree with the authors that the applicability of endo-
ascular aneurysm repair outside IFU should be reserved for those
enters with great experience in aortic endovascular procedures.
In other reports, we suggested the use of alternative procedures
fenestrated stent grafts, chimney technique) in selected patients with
long life expectancy and with stable lesions, even if these advanced
ndovascular techniques have still not resolved problems. In fact, the
